Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Facilitated access program for Everolimus maintenance after RAD solid organ transplant trials
2004-001473-25Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus in Solid organ transplant recipient (SOTR), sponsored by Novartis. Started Dec 2005; status: completed.
02
Drugs
everolimus
03
Conditions
Solid organ transplant recipient (SOTR)
Beyond the preview
Go deeper on 2004-001473-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001473-25.